Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with (64)Cu Using NOTA and NODAGA

Imaging using affibody molecules enables discrimination between breast cancer metastases with high and low expression of HER2, making appropriate therapy selection possible. This study aimed to evaluate if the longer half-life of (64)Cu (T(1/2) = 12.7 h) would make (64)Cu a superior nuclide compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolmachev, Vladimir, Yim, Cheng-Bin, Rajander, Johan, Perols, Anna, Karlström, Amelie Eriksson, Haaparanta-Solin, Merja, Grönroos, Tove J., Solin, Olof, Orlova, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612711/
https://www.ncbi.nlm.nih.gov/pubmed/29097939
http://dx.doi.org/10.1155/2017/8565802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612711/
https://www.ncbi.nlm.nih.gov/pubmed/29097939
http://dx.doi.org/10.1155/2017/8565802

Ejemplares similares